Literature DB >> 24717670

Genetic testing in cardiovascular diseases.

Anne-Karin Arndt1, Calum A MacRae.   

Abstract

PURPOSE OF REVIEW: The review is designed to outline the major developments in genetic testing in the cardiovascular arena in the past year or so. This is an exciting time in genetic testing as whole exome and whole genome approaches finally reach the clinic. These new approaches offer insight into disease causation in families in which this might previously have been inaccessible, and also bring a wide range of interpretative challenges. RECENT
FINDINGS: Among the most significant recent findings has been the extent of physiologic rare coding variation in the human genome. New disease genes have been identified through whole exome studies in neonatal arrhythmia, congenital heart disease and coronary artery disease that were simply inaccessible with other techniques. This has not only shed light on the challenges of genetic testing at this scale, but has also sharply defined the limits of prior gene-panel focused testing. As novel therapies targeting specific genetic subsets of disease become available, genetic testing will become a part of routine clinical care.
SUMMARY: The pace of change in sequencing technologies has begun to transform clinical medicine, and cardiovascular disease is no exception. The complexity of such studies emphasizes the importance of real-time communication between the genetics laboratory and genetically informed clinicians. New efforts in data and knowledge management will be central to the continued advancement of genetic testing.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24717670      PMCID: PMC4129647          DOI: 10.1097/HCO.0000000000000055

Source DB:  PubMed          Journal:  Curr Opin Cardiol        ISSN: 0268-4705            Impact factor:   2.161


  44 in total

Review 1.  Reduction of low-density lipoprotein cholesterol by monoclonal antibody inhibition of PCSK9.

Authors:  Evan A Stein; Frederick Raal
Journal:  Annu Rev Med       Date:  2014       Impact factor: 13.739

2.  Regulation: The FDA is overcautious on consumer genomics.

Authors:  Robert C Green; Nita A Farahany
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

3.  A pharmacogenetic versus a clinical algorithm for warfarin dosing.

Authors:  Stephen E Kimmel; Benjamin French; Scott E Kasner; Julie A Johnson; Jeffrey L Anderson; Brian F Gage; Yves D Rosenberg; Charles S Eby; Rosemary A Madigan; Robert B McBane; Sherif Z Abdel-Rahman; Scott M Stevens; Steven Yale; Emile R Mohler; Margaret C Fang; Vinay Shah; Richard B Horenstein; Nita A Limdi; James A S Muldowney; Jaspal Gujral; Patrice Delafontaine; Robert J Desnick; Thomas L Ortel; Henny H Billett; Robert C Pendleton; Nancy L Geller; Jonathan L Halperin; Samuel Z Goldhaber; Michael D Caldwell; Robert M Califf; Jonas H Ellenberg
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

Review 4.  Clinical screening and genetic testing.

Authors:  Rahul C Deo; Calum A MacRae
Journal:  Clin Lab Med       Date:  2010-12       Impact factor: 1.935

5.  Identification of a KCNQ1 polymorphism acting as a protective modifier against arrhythmic risk in long-QT syndrome.

Authors:  Sabine Duchatelet; Lia Crotti; Rachel A Peat; Isabelle Denjoy; Hideki Itoh; Myriam Berthet; Seiko Ohno; Véronique Fressart; Maria Cristina Monti; Cristina Crocamo; Matteo Pedrazzini; Federica Dagradi; Alessandro Vicentini; Didier Klug; Paul A Brink; Althea Goosen; Heikki Swan; Lauri Toivonen; Annukka M Lahtinen; Kimmo Kontula; Wataru Shimizu; Minoru Horie; Alfred L George; David-Alexandre Trégouët; Pascale Guicheney; Peter J Schwartz
Journal:  Circ Cardiovasc Genet       Date:  2013-07-15

6.  Recurrent gain-of-function mutation in PRKG1 causes thoracic aortic aneurysms and acute aortic dissections.

Authors:  Dong-chuan Guo; Ellen Regalado; Darren E Casteel; Regie L Santos-Cortez; Limin Gong; Jeong Joo Kim; Sarah Dyack; S Gabrielle Horne; Guijuan Chang; Guillaume Jondeau; Catherine Boileau; Joseph S Coselli; Zhenyu Li; Suzanne M Leal; Jay Shendure; Mark J Rieder; Michael J Bamshad; Deborah A Nickerson; Choel Kim; Dianna M Milewicz
Journal:  Am J Hum Genet       Date:  2013-08-01       Impact factor: 11.025

7.  A randomized trial of genotype-guided dosing of warfarin.

Authors:  Munir Pirmohamed; Girvan Burnside; Niclas Eriksson; Andrea L Jorgensen; Cheng Hock Toh; Toby Nicholson; Patrick Kesteven; Christina Christersson; Bengt Wahlström; Christina Stafberg; J Eunice Zhang; Julian B Leathart; Hugo Kohnke; Anke H Maitland-van der Zee; Paula R Williamson; Ann K Daly; Peter Avery; Farhad Kamali; Mia Wadelius
Journal:  N Engl J Med       Date:  2013-11-19       Impact factor: 91.245

8.  Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy.

Authors:  Ilaria Rigato; Barbara Bauce; Alessandra Rampazzo; Alessandro Zorzi; Kalliopi Pilichou; Elisa Mazzotti; Federico Migliore; Martina Perazzolo Marra; Alessandra Lorenzon; Marzia De Bortoli; Martina Calore; Andrea Nava; Luciano Daliento; Dario Gregori; Sabino Iliceto; Gaetano Thiene; Cristina Basso; Domenico Corrado
Journal:  Circ Cardiovasc Genet       Date:  2013-09-26

9.  Dysfunctional nitric oxide signalling increases risk of myocardial infarction.

Authors:  Jeanette Erdmann; Klaus Stark; Ulrike B Esslinger; Philipp Moritz Rumpf; Doris Koesling; Cor de Wit; Frank J Kaiser; Diana Braunholz; Anja Medack; Marcus Fischer; Martina E Zimmermann; Stephanie Tennstedt; Elisabeth Graf; Sebastian Eck; Zouhair Aherrahrou; Janja Nahrstaedt; Christina Willenborg; Petra Bruse; Ingrid Brænne; Markus M Nöthen; Per Hofmann; Peter S Braund; Evanthia Mergia; Wibke Reinhard; Christof Burgdorf; Stefan Schreiber; Anthony J Balmforth; Alistair S Hall; Lars Bertram; Elisabeth Steinhagen-Thiessen; Shu-Chen Li; Winfried März; Muredach Reilly; Sekar Kathiresan; Ruth McPherson; Ulrich Walter; Jurg Ott; Nilesh J Samani; Tim M Strom; Thomas Meitinger; Christian Hengstenberg; Heribert Schunkert
Journal:  Nature       Date:  2013-11-10       Impact factor: 49.962

10.  Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.

Authors:  Anne-Karin Arndt; Sebastian Schafer; Jorg-Detlef Drenckhahn; M Khaled Sabeh; Eva R Plovie; Almuth Caliebe; Eva Klopocki; Gabriel Musso; Andreas A Werdich; Hermann Kalwa; Matthias Heinig; Robert F Padera; Katharina Wassilew; Julia Bluhm; Christine Harnack; Janine Martitz; Paul J Barton; Matthias Greutmann; Felix Berger; Norbert Hubner; Reiner Siebert; Hans-Heiner Kramer; Stuart A Cook; Calum A MacRae; Sabine Klaassen
Journal:  Am J Hum Genet       Date:  2013-06-13       Impact factor: 11.025

View more
  15 in total

Review 1.  Gene scanning and heart attack risk.

Authors:  Andreas S Barth; Gordon F Tomaselli
Journal:  Trends Cardiovasc Med       Date:  2015-07-17       Impact factor: 6.677

Review 2.  Vascular Genetics: Presentations, Testing, and Prognostics.

Authors:  Aaron W Aday; Sarah E Kreykes; Christina L Fanola
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-11-13

Review 3.  Genetics of congenital heart disease.

Authors:  Jonathan J Edwards; Bruce D Gelb
Journal:  Curr Opin Cardiol       Date:  2016-05       Impact factor: 2.161

Review 4.  The genetic landscape of cardiomyopathy and its role in heart failure.

Authors:  Elizabeth M McNally; David Y Barefield; Megan J Puckelwartz
Journal:  Cell Metab       Date:  2015-02-03       Impact factor: 27.287

5.  Compendium of causative genes and their encoded proteins for common monogenic disorders.

Authors:  Tucker L Apgar; Charles R Sanders
Journal:  Protein Sci       Date:  2021-09-21       Impact factor: 6.993

Review 6.  Advances in the treatment of aortic valve disease: is it time for companion diagnostics?

Authors:  Robert B Hinton
Journal:  Curr Opin Pediatr       Date:  2014-10       Impact factor: 2.856

7.  IDENTIFYING NEW SUDDEN DEATH GENES.

Authors:  Barry London; Alexander M Greiner; Haider Mehdi; Rebecca Gutmann
Journal:  Trans Am Clin Climatol Assoc       Date:  2018

8.  Cardiovascular genetics: paying individual dividends.

Authors:  Elizabeth McNally
Journal:  Sci Transl Med       Date:  2014-06-04       Impact factor: 17.956

9.  Utility and limitations of exome sequencing as a genetic diagnostic tool for conditions associated with pediatric sudden cardiac arrest/sudden cardiac death.

Authors:  Mindy H Li; Jenica L Abrudan; Matthew C Dulik; Ariella Sasson; Joshua Brunton; Vijayakumar Jayaraman; Noreen Dugan; Danielle Haley; Ramakrishnan Rajagopalan; Sawona Biswas; Mahdi Sarmady; Elizabeth T DeChene; Matthew A Deardorff; Alisha Wilkens; Sarah E Noon; Maria I Scarano; Avni B Santani; Peter S White; Jeffrey Pennington; Laura K Conlin; Nancy B Spinner; Ian D Krantz; Victoria L Vetter
Journal:  Hum Genomics       Date:  2015-07-19       Impact factor: 4.639

10.  Personalized biochemistry and biophysics.

Authors:  Brett M Kroncke; Carlos G Vanoye; Jens Meiler; Alfred L George; Charles R Sanders
Journal:  Biochemistry       Date:  2015-04-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.